Mira Pharmaceuticals, Inc. Acquires Shares in Telomir Pharmaceuticals, Inc.

Mira Pharmaceuticals, Inc. has acquired 3,521,127 shares of common stock in Telomir Pharmaceuticals, Inc. as part of its acquisition of SKNY Pharmaceuticals, Inc. This transaction was reported in a Form 3 filing with the SEC. The shares are held directly by Mira Pharmaceuticals, Inc., and the company is now a 10% owner of Telomir Pharmaceuticals, Inc. The filing was signed by Erez Aminov, CEO of Mira Pharmaceuticals, Inc., and the period of report is September 29, 2025. This acquisition signifies a significant change in ownership and could impact the strategic direction of Telomir Pharmaceuticals, Inc.